The Economic Times27 Sept 2026, 4:47 pm IST
Epigral targets Rs 5,000 crore revenue by 2031 through capacity expansion
What happened
- Epigral plans to reach Rs 5,000 crore in revenue by the 2030-31 financial year.
- The company expects revenue of Rs 2,900 crore for the current financial year.
- Epigral is doubling its production capacity for CPVC Resin and Epichlorohydrin (ECH) at its Dahej plant.
- The company invested Rs 650 crore in these expansions using internal funds.
Key terms explained
Financial terms from this story, in everyday words.
- CPVC Resin
- A plastic material used to make pipes and fittings that can withstand high temperatures.
- Epichlorohydrin (ECH)
- A chemical used primarily in the production of epoxy resins.
- Internal accruals
- Funds generated by the company from its own business operations rather than borrowing from outside.
Original source
The Economic Times
Was this summary clear?
For information only — not investment advice.Summarized automatically; always check the original before acting.